APPLICATION
ANDA075461
TYPE
ANDA
ORIGINAL APPROVAL
2002-07-08
LATEST ACTION
2006-02-14
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
NIZATIDINEDiscontinued
NIZATIDINE 150MG · CAPSULE · ORAL
NIZATIDINEDiscontinued
NIZATIDINE 300MG · CAPSULE · ORAL
Approval history
2006-02-14Labeling · Supplement 10AP
2002-07-08OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.